These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 22212680)

  • 21. Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and Plasticity.
    Price R; Mercuri NB; Ledonne A
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of endothelial prostacyclin synthesis by protease-activated receptors: mechanisms and significance.
    Wheeler-Jones CP
    Pharmacol Rep; 2008; 60(1):109-18. PubMed ID: 18276992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Potential of Targeting Protease Activated Receptors in Cardiovascular Diseases.
    Bulani Y; Sharma SS
    Curr Pharm Des; 2015; 21(30):4392-9. PubMed ID: 26471318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiology and pathophysiology of proteinase-activated receptors (PARs): PARs in the respiratory system: cellular signaling and physiological/pathological roles.
    Kawabata A; Kawao N
    J Pharmacol Sci; 2005 Jan; 97(1):20-4. PubMed ID: 15655298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteinase-activated receptors (PARs) as targets for antiplatelet therapy.
    Cunningham M; McIntosh K; Bushell T; Sloan G; Plevin R
    Biochem Soc Trans; 2016 Apr; 44(2):606-12. PubMed ID: 27068977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteases display biased agonism at protease-activated receptors: location matters!
    Russo A; Soh UJ; Trejo J
    Mol Interv; 2009 Apr; 9(2):87-96. PubMed ID: 19401541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The multiple layers of signaling selectivity at protease-activated receptors.
    Kyriazis I; Ellul J; Katsakiori P; Panayiotakopoulos G; Flordellis C
    Curr Pharm Des; 2012; 18(2):161-74. PubMed ID: 22229576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Protease-Activated Receptors for the Development of Myocarditis: Possible Therapeutic Implications.
    Weithauser A; Witkowski M; Rauch U
    Curr Pharm Des; 2016; 22(4):472-84. PubMed ID: 26696253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protease activated receptors in cardiovascular function and disease.
    Barnes JA; Singh S; Gomes AV
    Mol Cell Biochem; 2004 Aug; 263(1-2):227-39. PubMed ID: 15524183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of protease-activated receptors in astrocytes evokes a novel neuroprotective pathway through release of chemokines of the growth-regulated oncogene/cytokine-induced neutrophil chemoattractant family.
    Wang Y; Luo W; Reiser G
    Eur J Neurosci; 2007 Dec; 26(11):3159-68. PubMed ID: 18005059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric modulation of protease-activated receptor signaling.
    Canto I; Soh UJ; Trejo J
    Mini Rev Med Chem; 2012 Aug; 12(9):804-11. PubMed ID: 22681248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation.
    Russell FA; McDougall JJ
    Inflamm Res; 2009 Mar; 58(3):119-26. PubMed ID: 19184346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protease-activated receptors: regulation of neuronal function.
    Saito T; Bunnett NW
    Neuromolecular Med; 2005; 7(1-2):79-99. PubMed ID: 16052040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain.
    Rohatgi T; Sedehizade F; Reymann KG; Reiser G
    Neuroscientist; 2004 Dec; 10(6):501-12. PubMed ID: 15534036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteinase activated-receptors-associated signaling in the control of gastric cancer.
    Sedda S; Marafini I; Caruso R; Pallone F; Monteleone G
    World J Gastroenterol; 2014 Sep; 20(34):11977-84. PubMed ID: 25232234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insight into the agonism of protease-activated receptors as an immunotherapeutic strategy.
    Jiang Y; Lu L
    J Biol Chem; 2024 Feb; 300(2):105614. PubMed ID: 38159863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors.
    Yonamine CM; Kondo MY; Nering MB; Gouvêa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT
    Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer.
    Arora P; Ricks TK; Trejo J
    J Cell Sci; 2007 Mar; 120(Pt 6):921-8. PubMed ID: 17344429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier.
    Oikonomopoulou K; Diamandis EP; Hollenberg MD
    Biol Chem; 2010 Apr; 391(4):299-310. PubMed ID: 20180639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The G protein-coupled protease receptor PAR (protease-activated receptor) as a novel target for drug development].
    Kawabata A
    Yakugaku Zasshi; 2001 Jan; 121(1):1-7. PubMed ID: 11201157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.